|Bid||55.10 x 800|
|Ask||55.18 x 1300|
|Day's Range||50.60 - 56.00|
|52 Week Range||50.60 - 97.38|
|Beta (3Y Monthly)||0.98|
|PE Ratio (TTM)||44.71|
|Earnings Date||Mar 26, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.75|
tumbled Tuesday after the food-safety and animal sciences company released disappointing quarterly earnings. The Lansing, Michigan-based company was trading down 9.1% to $55.06 as both net earnings for the fiscal third quarter and earnings per share slid. "The quarterly results we are reporting today reflect a number of challenges in the quarter, including continued weakness in the global animal protein market and currency translation headwinds," said John Adent, Neogen's president and chief executive, in a press statement.
The Lansing, Michigan-based company said it had profit of 25 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...
LANSING, Mich. , March 26, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that its revenues for the third quarter of its 2019 fiscal year, which ended Feb. 28 , were $97,700,000 ...
Neogen Corp NASDAQ/NGS:NEOGView full report here! Summary * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is low for NEOG with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold NEOG had net inflows of $2.65 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is strong relative to the trend shown over the past year. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
LANSING, Mich. , March 25, 2019 /PRNewswire/ -- Neogen's comprehensive line of tests to detect allergens in food products before they can reach consumers now includes simple and accurate tests for coconut ...
Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neogen Corporation (NASDAQ:NEOG), which is in the medical equipment business, and is based in United States, saw a double-digit share price rise of over 10% in the past couple ofRead More...
NEW YORK, Feb. 11, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The goal of this article is to Read More...
LANSING, Mich., Jan. 29, 2019 /PRNewswire/ -- Neogen Corporation (NEOG) announced today that its transition of the responsibilities from James Herbert to John Adent as the company's chief executive officer is now complete. Herbert will continue to serve as chairman of Neogen's Board of Directors, and as the company's director of strategic growth under the direction of Adent. Neogen named Adent to succeed Herbert as its CEO in July 2017.
Neogen's (NEOG) genomic business shows steady growth on acquisitions in Australia and Brazil. Stiff rivalry a cause of concern.
LANSING, Mich., Jan. 9, 2019 /PRNewswire/ -- Neogen Corporation (NEOG) announced today that it has promoted Dr. Jason Lilly to the newly created position of vice president of international business. Lilly joined Neogen in 2005, and has spent the past eight years as Neogen's vice president of corporate development. In his new role, Lilly will be responsible for maximizing the revenues and profits for Neogen's operations outside of the United States and Canada.
LANSING, Mich. , Jan. 2, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of the Edmonton -based Delta Genomics Centre — a major animal genomics laboratory ...
Does Neogen Corporation (NASDAQ:NEOG) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on research activities, so it is no wonder why they tend to generate millions in profits […]
Neogen (NEOG) delivered earnings and revenue surprises of 3.33% and -1.71%, respectively, for the quarter ended November 2018. Do the numbers hold clues to what lies ahead for the stock?